June 8, 2015 | The Israeli-American medical equipment company EndoChoice raised $96 million in its offering on the New York Stock Exchange at a company value of $366 million, after money. The offering, which was valued lower than expected, was led by JP Morgan and Bank of America. EndoChoice was founded in 2008 by Will Parks and Mark G. Gilreath and is headquartered in Alpharetta, Georgia.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments